Andrew G. Malik
Corporate inversions, a method by which U.S.-based companies relocate to lower-tax countries, have recently been the subject of heated debate and media coverage. President Obama criticized corporate inversions as one of the “most insidious tax loopholes out there.” The President’s desire to crack down on corporate inversions was reflected by a new set of Treasury Department regulations that make inversions much less appealing for U.S. companies. The regulations had the desired effect; a merger between Pfizer Inc. and Allergan PLC valued at over $150 billion, which would have been the largest merger in history for the pharmaceutical industry, was called off days after the regulations were announced. Allergan’s CEO criticized the Treasury regulations as “un-American” and “capricious.”
Volume 70, Issue 1 is on the way!
Attention Camden Alumni!
The Camden campus is gathering updated contact information from alumni. To update your contact information, click here and click on “Alumni Contact Information Update.” Update your contact and work information to stay better connected to the Law Review!
Additionally, If you are still in contact with Rutgers Law Journal alumni, please have them contact our Business Editor at email@example.com so we can add them to our alumni database.